TOXICITY OF LEAD IN CHILDREN TRIAL--CLINICAL CENTE

儿童铅毒性试验--临床中心

• 批准号: 2394014
• 负责人: J J CHISOLM
• 金额: $ 40万
• 依托单位: HUGO W. MOSER RES INST KENNEDY KRIEGER
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-30 至 1998-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2394014
• 关键词: TOXICITY; LEAD; CHILDREN; TRIAL; CLINICAL

The objectives of this trial are to test the hypothesis that oral chelation therapy of low-level lead poisoning in children prevents lead induced developmental delay. The objective of the Clinical Center contracts are to support the recruitment, randomization, treatment, evaluation, and follow-up of the children.

这项试验的目的是检验这样一种假设 儿童低度铅中毒的螯合疗法预防铅中毒 诱发性发育迟缓。 临床中心合同的目标是支持 患者的招募、随机化、治疗、评估和随访 孩子们。